Anand Kapila Kapur's most recent trade in Elanco Animal Health Inc was a trade of 603 Deferred Stock Units done . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Elanco Animal Health Inc | Kapila Kapur Anand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 603 | 8,085 | - | - | Deferred Stock Units | |
| Omega Healthcare Investors... | Kapila Kapur Anand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2025 | 6,150 | 42,405 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Kapila Kapur Anand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 821 | 7,481 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Kapila Kapur Anand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Nov 2024 | 18,169 | 84,659 (0%) | 0% | 0 | Common Stock | |
| Omega Healthcare Investors... | Kapila Kapur Anand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 5,756 | 33,772 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Anand Kapila Kapur | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 964 | 6,659 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Kapur Kapila Anand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2023 | 20,374 | 66,490 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | Kapila Kapur Anand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2023 | 1,278 | 5,695 | - | - | Deferred Stock Units | |
| Omega Healthcare Investors... | Kapila Kapur Anand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2023 | 7,076 | 25,721 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Kapila Kapur Anand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 1,529 | 2,987 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Kapila Kapur Anand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 1,428 | 4,416 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Kapila Kapur Anand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 18,649 | 46,116 (0%) | 0% | 0 | Common Stock | |
| Omega Healthcare Investors... | Kapila Kapur Anand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 9,237 | 17,021 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Kapila Kapur Anand | Director | Purchase of securities on an exchange or from another person at price $ 28.48 per share. | 01 Mar 2022 | 1,000 | 27,467 (0%) | 0% | 28.5 | 28,479 | Common Stock |
| Elanco Animal Health Inc | Kapila Kapur Anand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2021 | 168 | 1,458 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Kapila Kapur Anand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 7,307 | 26,467 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | Kapila Kapur Anand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 166 | 1,289 | - | - | Deferred Stock Units | |
| Omega Healthcare Investors... | Kapila Kapur Anand | Director | Purchase of securities on an exchange or from another person at price $ 28.32 per share. | 15 Nov 2021 | 1,000 | 14,676 (0%) | 0% | 28.3 | 28,318 | Common Stock |
| Elanco Animal Health Inc | Kapila Kapur Anand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2021 | 111 | 1,122 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Kapila Kapur Anand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 114 | 1,011 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Kapila Kapur Anand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2021 | 109 | 896 | - | - | Deferred Stock Units | |
| Omega Healthcare Investors... | Kapila Kapur Anand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2021 | 1,014 | 7,122 | - | - | Deferred Stock Units | |
| Omega Healthcare Investors... | Kapila Kapur Anand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2021 | 6,108 | 6,108 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Kapila Kapur Anand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 126 | 126 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Kapila Kapur Anand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 124 | 362 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Kapila Kapur Anand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 115 | 478 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Kapila Kapur Anand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 111 | 237 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Kapila Kapur Anand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 105 | 685 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Kapila Kapur Anand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 101 | 579 | - | - | Deferred Stock Units | |
| Elanco Animal Health Inc | Kapila Kapur Anand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 100 | 786 | - | - | Deferred Stock Units |